After dementia onset, GC discontinuation and b/tsDMARD monotherapy increased, but some also experienced longer periods without DMARDs. (2/2) #JCR2025 #TheJapanCollegeofRheumatology

Symposium 8 (Planning by International Committee): Symposium 8 will present cutting-edge findings in the study of the pathogenesis of rheumatic diseases using single cell sequencing technology. (1/2) #JCR2025 #TheJapanCollegeofRheumatology

If you are interested in the new clinical immunology opened up by single cell resolution, please come and join us. (2/2) #JCR2025 #TheJapanCollegeofRheumatology

Symposium 9: To elucidate the pathomechanisms of systemic sclerosis (SSc), the comprehensive and single cell analysis, artificial intelligence (AI) has been proactively utilized. (1/2) #JCR2025 #TheJapanCollegeofRheumatology

This symposium will introduce the latest findings by invited researchers from Japan and overseas. The basic language will be English with AI Translation implemented. We look forward to your attendance. (2/2) #JCR2025 #TheJapanCollegeofRheumatology

Apr. 25, 16:45-17:45 LBA3-4 Yoshiya Tanaka (The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) (1/3) #JCR2025 #TheJapanCollegeofRheumatology

The post-hoc analysis of an integrated safety dataset of filgotinib (FIL) evaluated long-term safety up to 6 years in subgroup of Japanese patients with moderate-to-severe RA. (2/3) #JCR2025 #TheJapanCollegeofRheumatology

From data as of May 2023, incidence rates of AEs in the FIL200 and FIL100 group were analyzed, and no new safety concerns were found. (3/3) #JCR2025 #TheJapanCollegeofRheumatology

16:45-17:45 LBA3-5 Yoshiya Tanaka (University of Occupational and Environmental Health, Japan) Prof. Yoshiya Tanaka presents findings at JCR 2025 from the year-long PROFILE-J study. (1/2) #JCR2025 #TheJapanCollegeofRheumatology

It reveals how sarilumab can be used on its own and in combination with other drugs to treat 1998 Japanese patients with rheumatoid arthritis, including older patients. (2/2) #JCR2025 #TheJapanCollegeofRheumatology

Symposium 21 (Planning by International Committee): The aim of this symposium is to understand autoinflammatory diseases. (1/2) #JCR2025 #TheJapanCollegeofRheumatology

Special talks by international opinion leaders about Overview, Inflammasomopathy, Type I interferonopathy, IL-18opathy, and Still’s disease are scheduled. (2/2) #JCR2025 #TheJapanCollegeofRheumatology

Apr. 25, 16:45-17:45 LBA3-6 Yoshiya Tanaka (The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) (1/2) #JCR2025 #TheJapanCollegeofRheumatology

Prof. Tanaka presents findings from the observational PROFILE-J study at JCR 2025, evaluating the safety of sarilumab in 1998 patients with rheumatoid arthritis and how patients reported improvements in their ability in active lives.(2/2) #JCR2025 #TheJapanCollegeofRheumatology

Just like last year, we’ve prepared wonderful prizes that you can get based on the number of stamps you collected at the special exhibition booths. (1/2) #JCR2025 #TheJapanCollegeofRheumatology

This year, we have “Minamiyamate Pudding” and “Castera (Japanese Sponge Cake) in Original Package” for you. We look forward to your participation! For more details, please check the JCR2025 website. (2/2) jcr2025.com/en/stamprally/…… #JCR2025 #TheJapanCollegeofRheumatology

Prof. Allan Gibofsky, who was scheduled to speak at the TREG session on Friday, April 25, is unable to attend due to illness. Dr. Kei Ikeda (Dokkyo Medical University) will be presenting in his behalf accordingly. (1/2) #JCR2025 #TheJapanCollegeofRheumatology

TS-1: Systemic Lupus Erythematosus and Autoimmune Rheumatic Disorders (2/2) #JCR2025 #TheJapanCollegeofRheumatology

On-demand broadcast of Educational Lectures (Japanese) is now available. You can watch the lectures at My Page on the registration system. (Distribution period: May 1 (Thu), 2025, 5:00pm - May 30(Fri), 2025, noon) miceregi.jp/reg/jcr2025/my… #JCR2025 #TheJapanCollegeofRheumatology

We have extended the early bird registration for #APLAR25 and it's now OPEN. Join APAC’s leading #rheumatology Congress in the historically rich city of #Fukuoka. Register before the extended deadline: 20 May 2025 Register here: tinyurl.com/Registration-25